Multi-center real-world data curation and assessment of tumor growth rate and overall survival in advanced NSCLC treated with PD-(L)1 immune checkpoint inhibitor therapy.

Authors

null

Chiharu Sako

Onc.AI, San Carlos, CA

Chiharu Sako , Petr Jordan , Ross McCall , Arpan Patel , Dwight Hall Owen , Arya Amini , An Liu , Brendan D. Curti , Roshanthi K. Weerasinghe , Soohee Lee , Ray D. Page , Aurélie Swalduz , Jean-Paul Beregi , Stéphane Sanchez , Olivier Gevaert , Ravi Bharat Parikh , George R. Simon , Hugo Aerts

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9124)

DOI

10.1200/JCO.2023.41.16_suppl.9124

Abstract #

9124

Poster Bd #

112

Abstract Disclosures